Cognitive & Memory Enhancer Drugs Market - Global Forecast 2026-2032

The Cognitive & Memory Enhancer Drugs Market is undergoing transformation as scientific advances, new regulatory policies, and rising patient expectations shape pathways for therapy development and distribution. Senior leaders need clear insight into operational, clinical, and channel dynamics to inform strategic decision-making in this innovation-driven sector.

Market Snapshot: Cognitive & Memory Enhancer Drugs Market

In 2025, the global Cognitive & Memory Enhancer Drugs Market reached a valuation of USD 7.13 billion and is projected to grow to USD 7.84 billion by 2026. A compound annual growth rate (CAGR) of 10.95% is forecasted, with the market set to achieve USD 14.77 billion by 2032. This growth is led by surging demand for innovative treatments, enhanced patient outcomes, and broadened accessibility through multiple care channels and therapeutic choices.

Scope & Segmentation

Drug Classes: Incorporates cholinesterase inhibitors, including donepezil, galantamine, and rivastigmine, NMDA antagonists, psychostimulants such as amphetamines and methylphenidate, racetams like aniracetam and piracetam, and a pipeline of emerging therapeutic modalities.
Dosage Forms: Encompasses tablets, capsules, injectables, and oral powders, addressing diverse preferences and enhancing adherence for different patient populations.
Therapeutic Applications: Serves a range of clinical needs, from Alzheimer’s and Parkinson’s disease to attention deficit hyperactivity disorder and broader cognitive enhancement, meeting the requirements of both specialty populations and general cognitive wellness.
Distribution Channels: Includes hospital pharmacies, retail outlets, and online pharmacies, ensuring patient access across healthcare environments and adapting to shifts in buying behaviors.
End-Users: Supports hospitals, specialty clinics, and outpatient care providers, enabling wider outreach to aging demographics and neurologically impaired individuals.
Geographies: Spans the Americas, Europe Middle East & Africa, and Asia-Pacific, tracking trends, regulatory diversity, and tailored growth approaches relevant to each regional landscape.
Technology Considerations: Adopts digital therapeutics, remote patient monitoring, telemedicine-enabled prescribing, enhanced packaging, and automated manufacturing to streamline delivery, personalize therapy, and maintain supply chain efficiency.

Key Takeaways

Neuroscience breakthroughs are shifting drug development toward more personalized approaches, aligning products with distinct cognitive characteristics and clinical nuances.
Broadening dosage form offerings is essential, improving treatment adherence especially among elderly and neurologically affected patients by catering to their specific needs.
Stakeholders are placing emphasis on collecting real-world usage and safety data to meet growing demands from regulatory agencies and reimbursement bodies for clear evidence of clinical and economic value.
Digital health solutions, such as online pharmacies and integrated platforms, are optimizing how therapies are distributed and accessed, expanding patient reach and convenience.
Success now depends on coordinated strategies that bring together clinical, regulatory, and operational functions to support ongoing product innovation, optimal channel management, and efficient adaptation in distinct regional markets.

Tariff Impact & Supply Chain Realignment

Evolving tariff regulations and trade policy shifts have increased supply chain complexity for cognitive and memory therapeutic products. Manufacturers are strategically reassessing global sourcing practices, creating regional production bases, and investing in supplier diversification. Automation and local manufacturing are central to minimizing risks and ensuring supply continuity. These adaptations are supporting robust procurement processes, uninterrupted product availability, and sustained market competitiveness despite global trade challenges.

Methodology & Data Sources

This analysis synthesizes data from peer-reviewed scientific studies, regulatory updates, clinical trial registries, key expert interviews, and company disclosures. Drawing from multiple data channels ensures robust conclusions about segment performance, shifting regulations, and ongoing technology implementations in the Cognitive & Memory Enhancer Drugs Market.

Why This Report Matters

Guides decision-makers on strategic portfolio planning, research priorities, and commercial launch timing as this sector evolves.
Offers forward-looking insights that clarify changing regulations, entry requirements, and the business impact of new distribution or regional models.
Empowers operational leaders to strengthen supply chains, improve procurement, and ensure expanded patient access using data-backed recommendations tailored to real-world conditions.

Conclusion

Navigating the Cognitive & Memory Enhancer Drugs Market demands continual alignment between innovation, manufacturing agility, and proactive supply chain management. Sustained investment in evidence generation remains key to advancing patient outcomes and market acceptance.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Cognitive & Memory Enhancer Drugs Market, by Mechanism Of Action

8.1. Cholinesterase Inhibitors
8.1.1. Donepezil
8.1.2. Galantamine
8.1.3. Rivastigmine
8.2. NMDA Antagonists
8.3. Psychostimulants
8.3.1. Amphetamines
8.3.2. Methylphenidate
8.4. Racetams
8.4.1. Aniracetam
8.4.2. Piracetam

9. Cognitive & Memory Enhancer Drugs Market, by Dosage Form

9.1. Capsules
9.2. Injectable
9.3. Oral Powder
9.4. Tablets

10. Cognitive & Memory Enhancer Drugs Market, by Application

10.1. Alzheimer's Disease
10.2. Attention Deficit Hyperactivity Disorder
10.3. General Cognitive Enhancement
10.4. Parkinson's Disease

11. Cognitive & Memory Enhancer Drugs Market, by Distribution Channel

11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.3. Retail Pharmacies

12. Cognitive & Memory Enhancer Drugs Market, by End User

12.1. Clinics
12.2. Hospitals

13. Cognitive & Memory Enhancer Drugs Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Cognitive & Memory Enhancer Drugs Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Cognitive & Memory Enhancer Drugs Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Cognitive & Memory Enhancer Drugs Market
17. China Cognitive & Memory Enhancer Drugs Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc
18.6. Allergan Plc
18.7. AstraZeneca plc
18.8. Bayer AG
18.9. Biogen Inc
18.10. Eisai Co., Ltd
18.11. Eli Lilly and Company
18.12. GlaxoSmithKline plc
18.13. Johnson & Johnson
18.14. Lundbeck A/S
18.15. Merck & Co., Inc.
18.16. Novartis AG
18.17. Pfizer Inc
18.18. Roche Holding AG
18.19. Sanofi S.A.
18.20. Takeda Pharmaceutical Company Limited
18.21. Teva Pharmaceutical Industries Limited

List of Figures

FIGURE 1. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 122. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 125. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. EUROPE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 139. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 140. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 142. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 143. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 158. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 159. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 160. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 161. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 162. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. ASEAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 167. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 168. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 169. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 170. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 171. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 172. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. GCC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 185. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 186. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 187. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 188. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 189. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. BRICS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 194. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 195. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 196. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 197. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 198. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. G7 COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 203. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 204. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 205. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 206. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 207. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 209. NATO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 222. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2032 (USD MILLION)
TABLE 223. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2032 (USD MILLION)
TABLE 224. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2032 (USD MILLION)
TABLE 225. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 226. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cognitive & Memory Enhancer Drugs market report include:

AbbVie Inc
Allergan Plc
AstraZeneca plc
Bayer AG
Biogen Inc
Eisai Co., Ltd
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Lundbeck A/S
Merck & Co., Inc.
Novartis AG
Pfizer Inc
Roche Holding AG
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Limited

Table Information

Report Attribute	Details
No. of Pages	189
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 7.84 Billion
Forecasted Market Value ( USD ) by 2032	$ 14.77 Billion
Compound Annual Growth Rate	10.9%
Regions Covered	Global
No. of Companies Mentioned	18

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Cognitive & Memory Enhancer Drugs Market

Scope & Segmentation

Key Takeaways

Tariff Impact & Supply Chain Realignment

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cognitive and Memory Enhancer Drugs Market 2025-2033

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025

Dementia Associated with Alzheimer's Disease Market - Global Strategic Business Report

Dementia Treatment Market Report 2025

Memory Enhancement Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F